XIAP and cIAP1 amplifications induce Beclin 1-dependent autophagy through NFκB activation

Human Molecular Genetics

Volumn 24, Issue 10, 2015, Pages 2899-2913

  Lin, Fang ^a,b   Ghislat, Ghita ^a   Luo, Shouqing ^a   Renna, Maurizio ^a   Siddiqi, Farah ^a   Rubinsztein, David C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BECLIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; SYNAPTOTAGMIN I; UBIQUITIN PROTEIN LIGASE E3; X LINKED INHIBITOR OF APOPTOSIS; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; BIRC2 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MEMBRANE PROTEIN; UBIQUITIN PROTEIN LIGASE; XIAP PROTEIN, HUMAN;

ARTICLE; AUTOPHAGY; B CELL LYMPHOMA; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; GENETICS; METABOLISM; PHYSIOLOGY;

INTRACISTERNAL A-PARTICLES;

APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BECLIN-1; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MEMBRANE PROTEINS; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UBIQUITIN-PROTEIN LIGASES; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84929756892     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv052     Document Type: Article

References (46)

1. Su, M., Mei, Y. and Sinha, S. (2013) Role of the crosstalk between autophagy and apoptosis in cancer. J. Oncol., 2013, 102735.
2. Rubinsztein, D.C., Codogno, P. and Levine, B. (2012) Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov., 11, 709-730.
3. Rosenfeldt, M.T., O'Prey, J., Morton, J.P., Nixon, C., MacKay, G., Mrowinska, A., Au, A., Rai, T.S., Zheng, L., Ridgway, R. et al. (2013) p53 status determines the role of autophagy in pancreatic tumour development. Nature, 504, 296-300.
4. Morselli, E., Galluzzi, L., Kepp, O., Vicencio, J.M., Criollo, A., Maiuri, M.C. and Kroemer, G. (2009) Anti- and pro-tumor functions of autophagy. Biochim. Biophys. Acta, 1793, 1524-1532.
5. Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., Rosen, J., Eskelinen, E.L., Mizushima, N., Ohsumi, Y. et al. (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest., 112, 1809-1820.
6. Yue, Z., Jin, S., Yang, C., Levine, A.J. and Heintz, N. (2003) Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl Acad. Sci. USA, 100, 15077-15082.
7. Chen, H.Y. and White, E. (2011) Role of autophagy in cancer prevention. Cancer Prev. Res. (Phila), 4, 973-983.
8. Silke, J. and Meier, P. (2013) Inhibitor of apoptosis (IAP) proteins- modulators of cell death and inflammation. Cold Spring Harb. Perspect. Biol., 5. doi: 10.1101/cshperspect.a008730.
9. Yang, Y., Fang, S., Jensen, J.P., Weissman, A.M. and Ashwell, J.D. (2000) Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science, 288, 874-877.
10. Gyrd-Hansen, M., Darding, M., Miasari, M., Santoro, M.M., Zender, L., Xue, W., Tenev, T., da Fonseca, P.C., Zvelebil, M., Bujnicki, J.M. et al. (2008) IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis. Nat. Cell. Biol., 10, 1309-1317.
11. Fulda, S. (2012) Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers. Cancer Treat. Rev., 38, 760-766.
12. Jaffer, S., Orta, L., Sunkara, S., Sabo, E. and Burstein, D.E. (2007) Immunohistochemical detection of antiapoptotic protein Xlinked inhibitor of apoptosis in mammary carcinoma. Hum. Pathol., 38, 864-870.
13. Kluger, H.M., McCarthy, M.M., Alvero, A.B., Sznol, M., Ariyan, S., Camp, R.L., Rimm, D.L. and Mor, G. (2007) The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization. J. Transl. Med., 5, 6.
14. Ramp, U., Krieg, T., Caliskan, E., Mahotka, C., Ebert, T.,Willers, R., Gabbert, H.E. and Gerharz, C.D. (2004) XIAP expression is an independent prognostic marker in clear-cell renal carcinomas. Hum. Pathol., 35, 1022-1028.
15. Parton, M., Krajewski, S., Smith, I., Krajewska, M., Archer, C., Naito, M., Ahern, R., Reed, J. and Dowsett, M. (2002) Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy. Clin. Cancer Res., 8, 2100-2108.
16. Hofmann, H.S., Simm, A., Hammer, A., Silber, R.E. and Bartling, B. (2002) Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer. J. Cancer Res. Clin. Oncol., 128, 554-560.
17. Liu, S., Zhang, P., Chen, Z., Liu, M., Li, X. and Tang, H. (2013) MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells. FEBS Lett., 587, 2247-2253.
18. Eschenburg, G., Eggert, A., Schramm, A., Lode, H.N. and Hundsdoerfer, P. (2012) Smac mimetic LBW242 sensitizes XIAP-overexpressing neuroblastoma cells for TNF-alpha-independent apoptosis. Cancer Res., 72, 2645-2656.
19. Fulda, S. (2012) Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies. Leukemia, 26, 1155-1165.
20. Tamm, I., Kornblau, S.M., Segall, H., Krajewski, S., Welsh, K., Kitada, S., Scudiero, D.A., Tudor, G., Qui, Y.H., Monks, A. et al. (2000) Expression and prognostic significance of IAPfamily genes in human cancers and myeloid leukemias. Clin. Cancer Res., 6, 1796-1803.
21. Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y. and Yoshimori, T. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J., 19, 5720-5728.
22. Menzies, F.M., Moreau, K., Puri, C., Renna, M. and Rubinsztein, D.C. (2012) Measurement of autophagic activity in mammalian cells. Curr. Protoc. Cell. Biol., Chapter 15, Unit 15 16.
23. Klionsky, D.J., Abdalla, F.C., Abeliovich, H., Abraham, R.T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J.A. et al. (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy, 8, 445-544.
24. Kimura, S., Noda, T. and Yoshimori, T. (2007) Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy, 3, 452-460.
25. Nikolovska-Coleska, Z., Xu, L., Hu, Z., Tomita, Y., Li, P., Roller, P.P.,Wang, R., Fang, X., Guo, R., Zhang, M. et al. (2004) Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J. Med. Chem., 47, 2430-2440.
26. Ahn, K.S., Sethi, G. and Aggarwal, B.B. (2007) Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products. Mol. Pharmacol., 71, 209-219.
27. Korolchuk,V.I.,Mansilla,A.,Menzies, F.M. andRubinsztein,D.C. (2009) Autophagy inhibition compromises degradation of ubiquitin- proteasome pathway substrates. Mol. Cell, 33, 517-527.
28. Ravikumar, B., Duden, R. and Rubinsztein, D.C. (2002) Aggregate- prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet, 11, 1107-1117.
29. Axe, E.L.,Walker, S.A., Manifava, M., Chandra, P., Roderick, H. L., Habermann, A., Griffiths, G. and Ktistakis, N.T. (2008) Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J. Cell Biol., 182, 685-701.
30. Copetti, T., Bertoli, C., Dalla, E., Demarchi, F. and Schneider, C. (2009) p65/RelA modulates BECN1 transcription and autophagy. Mol. Cell Biol., 29, 2594-2608.
31. Ravikumar, B., Imarisio, S., Sarkar, S., O'Kane, C.J. and Rubinsztein, D.C. (2008) Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease. J. Cell Sci., 121, 1649-1660.
32. Lu, M., Lin, S.C., Huang, Y., Kang, Y.J., Rich, R., Lo, Y.C.,Myszka, D., Han, J. and Wu, H. (2007) XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol. Cell, 26, 689-702.
33. Freudlsperger, C., Bian, Y., ContagWise, S., Burnett, J., Coupar, J., Yang, X., Chen, Z. and Van Waes, C. (2013) TGF-beta and NF-kappaB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene, 32, 1549-1559.
34. Oeckinghaus, A. and Ghosh, S. (2009) The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol., 1, a000034.
35. Hussain, A.R., Uddin, S., Ahmed, M., Bu, R., Ahmed, S.O., Abubaker, J., Sultana, M., Ajarim, D., Al-Dayel, F., Bavi, P.P. et al. (2010) Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling. J. Pathol., 222, 180-190.
36. Gyrd-Hansen,M. and Meier, P. (2010) IAPs: fromcaspase inhibitors tomodulators of NF-kappaB, inflammation and cancer. Nat. Rev. Cancer, 10, 561-574.
37. Sinha, S. and Levine, B. (2008) The autophagy effector Beclin 1: a novel BH3-only protein. Oncogene, 27(Suppl. 1), S137-S148.
38. Huang, X., Wu, Z., Mei, Y. and Wu, M. (2013) XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling. EMBO J., 32, 2204-2216.
39. LaCasse, E.C., Mahoney, D.J., Cheung, H.H., Plenchette, S., Baird, S. and Korneluk, R.G. (2008) IAP-targeted therapies for cancer. Oncogene, 27, 6252-6275.
40. Petersen, S.L., Wang, L., Yalcin-Chin, A., Li, L., Peyton, M., Minna, J., Harran, P. andWang, X. (2007) Autocrine TNFalpha signaling renders human cancer cells susceptible to Smacmimetic- induced apoptosis. Cancer Cell, 12, 445-456.
41. White, E. (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer, 12, 401-410.
42. Laddha, S.V., Ganesan, S., Chan, C.S. and White, E. (2014) Mutational landscape of the essential autophagy gene BECN1 in human cancers. Mol. Cancer Res., 12, 485-490.
43. Yang, A., Rajeshkumar, N.V.,Wang, X., Yabuuchi, S., Alexander, B.M., Chu, G.C., Von Hoff, D.D., Maitra, A. and Kimmelman, A.C. (2014) Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. Cancer Discov., 4, 905-913.
44. Csomos, R.A., Wright, C.W., Galban, S., Oetjen, K.A. and Duckett, C.S. (2009) Two distinct signalling cascades target the NF-kappaB regulatory factor c-IAP1 for degradation. Biochem. J., 420, 83-91.
45. Puca, A., Fiume, G., Palmieri, C., Trimboli, F., Olimpico, F., Scala, G. and Quinto, I. (2007) IkappaB-alpha represses the transcriptional activity of theHIV-1 Tat transactivator by promoting its nuclear export. J. Biol. Chem., 282, 37146-37157.
46. Sarkar, S., Krishna, G., Imarisio, S., Saiki, S., O'Kane, C.J. and Rubinsztein, D.C. (2008) A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin. Hum. Mol.Genet., 17, 170-178.